These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28537656)

  • 1. Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome.
    Belcaro G; Gizzi G; Pellegrini L; Corsi M; Dugall M; Cacchio M; Feragalli B; Togni S; Riva A; Eggenhoffner R; Giacomelli L
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2249-2254. PubMed ID: 28537656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of a lecithin-based delivery form of boswellic acids (Casperome®) for the prevention of symptoms of irritable bowel syndrome: a randomized clinical study.
    Riva A; Giacomelli L; Togni S; Franceschi F; Eggenhoffner R; Zuccarini MC; Belcaro G
    Minerva Gastroenterol Dietol; 2019 Mar; 65(1):30-35. PubMed ID: 30676012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract.
    Pellegrini L; Milano E; Franceschi F; Belcaro G; Gizzi G; Feragalli B; Dugall M; Luzzi R; Togni S; Eggenhoffner R; Giacomelli L
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2695-700. PubMed ID: 27383325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel lecithin based delivery form of Boswellic acids (Casperome®) for the management of osteo-muscular pain: a registry study in young rugby players.
    Franceschi F; Togni S; Belcaro G; Dugall M; Luzzi R; Ledda A; Pellegrini L; Eggenhoffner R; Giacomelli L
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):4156-4161. PubMed ID: 27775780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial Effects on Abdominal Bloating with an Innovative Food-Grade Formulation of
    Giacosa A; Riva A; Petrangolini G; Allegrini P; Fazia T; Bernardinelli L; Peroni G; Rondanelli M
    Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pycnogenol® supplementation improves the control of irritable bowel syndrome symptoms.
    Belcaro G; Gizzi G; Pellegrini L; Feragalli B; Cotellese R; Cacchio M; Corsi M
    Panminerva Med; 2018 Jun; 60(2):65-69. PubMed ID: 29737150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel boswellic acids delivery form (Casperome®) in the management of musculoskeletal disorders: a review.
    Riva A; Allegrini P; Franceschi F; Togni S; Giacomelli L; Eggenhoffner R
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5258-5263. PubMed ID: 29228442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study.
    Hawrelak JA; Myers SP
    J Altern Complement Med; 2010 Oct; 16(10):1065-71. PubMed ID: 20954962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive Effects of a Lecithin-Based Delivery Form of
    Giacosa A; Riva A; Petrangolini G; Allegrini P; Fazia T; Bernardinelli L; Peroni G; Rondanelli M
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Bensoussan A; Kellow JE; Bourchier SJ; Fahey P; Shim L; Malcolm A; Boyce P
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1946-54.e1. PubMed ID: 26133902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of a novel boswellic acids delivery form (Casperome®) in the management of grade II ankle sprains due to sport trauma - a registry study.
    Feragalli B; Ippolito E; Dugall M; Cacchio M; Belcaro G; Cesarone MR; Abdel-Tawab M; Riva A; Togni S; Eggenhoffner R; Giacomelli L
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4726-4732. PubMed ID: 29131239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Chen C; Tao C; Liu Z; Lu M; Pan Q; Zheng L; Li Q; Song Z; Fichna J
    Phytother Res; 2015 Nov; 29(11):1822-7. PubMed ID: 26400188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome.
    Fiorini G; Saracino IM; Pavoni M; Nipote B; Colucci R; Capone P; Sannino A; Forte F; DE Vergori E; Brancaccio M; Cesareo M; Casella G; Morreale GC; Bonfrate L; Portincasa P; Vincenzi M; Cottone C; Ormando VM; Scalise N; Lawson PF; Burattini O; Montale A; Luzza F; Rossi M; Vanni R; Bozzi R; Vincoli G; Stefani N; Borghi C; Vaira D
    Minerva Gastroenterol (Torino); 2023 Mar; 69(1):123-127. PubMed ID: 36856276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of irritable bowel syndrome with a novel colonic irrigation system: a pilot study.
    Hsu HH; Leung WH; Hu GC
    Tech Coloproctol; 2016 Aug; 20(8):551-7. PubMed ID: 27194235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: a pilot study.
    Bundy R; Walker AF; Middleton RW; Booth J
    J Altern Complement Med; 2004 Dec; 10(6):1015-8. PubMed ID: 15673996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
    Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
    Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
    Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
    Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation.
    Johnston JM; Shiff SJ; Quigley EM
    Curr Med Res Opin; 2013 Feb; 29(2):149-60. PubMed ID: 23198977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifaximin therapy for patients with irritable bowel syndrome without constipation.
    Pimentel M; Lembo A; Chey WD; Zakko S; Ringel Y; Yu J; Mareya SM; Shaw AL; Bortey E; Forbes WP;
    N Engl J Med; 2011 Jan; 364(1):22-32. PubMed ID: 21208106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.